Scarica l'app Stockscreener
1.31
0.76%
-0.01
Dopo l'orario di chiusura:
1.30
-0.01
-0.76%
Precedente Chiudi:
$1.32
Aprire:
$1.3
Volume 24 ore:
118.10K
Relative Volume:
0.12
Capitalizzazione di mercato:
$6.58M
Reddito:
-
Utile/perdita netta:
$-27.39M
Rapporto P/E:
-0.7796
EPS:
-1.6803
Flusso di cassa netto:
$-2.09M
1 W Prestazione:
-9.66%
1M Prestazione:
-0.76%
6M Prestazione:
-93.60%
1 anno Prestazione:
-95.75%
Intervallo 1D:
$1.2408
$1.34
Intervallo di 1 settimana:
$1.2408
$1.5918
Portata 52W:
$1.20
$36.48
Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile
Nome
Aspire Biopharma Holdings Inc
Settore
Industria
Telefono
561-704-8527
Indirizzo
23150 FASHION DRIVE, SUITE 232, ESTERO
Compare ASBP vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ASBP
Aspire Biopharma Holdings Inc
|
1.31 | 6.63M | 0 | -27.39M | -2.09M | -1.6803 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Aspire Biopharma Holdings Inc Borsa (ASBP) Ultime notizie
ASBP SEC FilingsAspire Biopharma Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ASBP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements - The Sheboygan Press
Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity - Bergen Record
Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief - ACCESS Newswire
New under-the-tongue alprazolam powder aims to calm anxiety faster - Stock Titan
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution - Oak Ridger
Aspire Biopharma Provides Q3 2025 Business Update - Las Cruces Sun-News
Aspire Biopharma Announces Reverse Stock Split - Daily American
Aspire Biopharma Holdings, Inc.Common Stock (NQ: ASBP - The Chronicle-Journal
ASBP Technical Analysis & Stock Price Forecast - Intellectia AI
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit - Victorville Daily Press
ASBP Technical Analysis & ETF Price Forecast - Intellectia AI
ASBP Should I Buy - Intellectia AI
Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship - Digital Journal
Aspire Biopharma Holdings, Inc.: Aspire Biopharma's Buzz Bomb Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship - FinanzNachrichten.de
Aspire Biopharma's Unveils Bold New Era for BUZZ BOMB(TM) Caffeine with Dynamic Website and Packaging Redesign - Pocono Record
Aspire Biopharma (ASBP) seeks reverse split, $100M equity line and share increase - Stock Titan
Aspire Biopharma Holdings Inc Azioni (ASBP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.69%
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):